
Govt should absorb cost of care for cadets disabled in training: Former service chiefs
These are some of the key suggestions put forward by two former service chiefs and a retired top military official while responding to a report Monday by The Indian Express on the plight of some of these cadets who are battling severe disability, from paralysis to brain damage, with shattered dreams and poor benefits.
'We must take care of these unfortunate cases. Such cases would be few and the Government should be able to absorb that cost,' former Army Chief General M M Naravane (retd) said.
'As young men and women who are motivated to volunteer for service in the armed forces, we are duty bound to ensure reasonable compensation in case of withdrawal from training due to injury,' said former Navy Chief Admiral Arun Prakash (retd), who has also served as commandant of the National Defence Academy (NDA).
In a series of two reports, The Indian Express found that around 500 officer cadets have been medically discharged from military institutes such as NDA since 1985, due to varying degrees of disability incurred during training. At the NDA alone, sources told this newspaper, around 20 such cadets were medically discharged in just the past five years, between 2021 and July 2025.
This newspaper also reported that while Defence Minister Rajnath Singh had okayed a proposal to increase the ex gratia awarded in such cases (a maximum of about Rs 40,000 per month currently), the file was stuck. The parents of these cadets told this newspaper that the ex gratia was far short of what they needed for their sons who required lifelong care and attention.
Gen Naravane said it is important to take particular care of cadets with debilitating injuries. 'This could include more ways for better health insurance and treatment at military hospitals,' he said. At the same time, he cautioned that while rules should be more sympathetic to such cases, they should be foolproof too to avoid misuse.
Incidentally, Gen Naravane's father was medically boarded out from the Indian Military Academy (IMA) as an Army cadet. He proceeded to complete his graduation and went on to join the IAF.
Admiral Prakash, meanwhile, said it is the duty of training institutions to ensure the full medical fitness of cadets for every physical activity that they are required to undergo. 'Staff must exercise utmost care to ensure the safety of trainees for all training,' he said.
Stating that rules should be drawn up for the Government to insure each cadet at the time of joining for the entire period of training, Admiral Prakash emphasised that instead of terming the compensation as 'ex gratia', which implies 'out of pity', it should be made an 'entitlement'.
Additionally, he said, a medical board should decide the additional amount to be granted depending on severity of injury, duration of treatment, chances of recovery and financial capacity of parents.
Asked about the demand from parents that these cadets should get ex-servicemen (ESM) status, which would make them eligible under the Ex-Servicemen Contributory Health Scheme (ECHS) for free treatment at military facilities and empanelled hospitals, Admiral Prakash said the current rules may not make it legally feasible.
However, a third top military official The Indian Express spoke to, who retired from the IAF, said the primary issue is the grant of ESM status. 'Having an ESM card opens doors to employment opportunities, or even mundane things like entry into a cantonment to meet coursemates,' the former top officer said.
He said similar issues exist with Short Service Commission (SSC) officers. 'SSC saves a huge pension bill, but those who get boarded out shortly after commissioning also do not get ESM status or any benefit,' he said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hans India
an hour ago
- Hans India
AstraZeneca Pharma India's net profit slips 4 pc in Q1
Mumbai: AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1) of FY26, with earnings falling to Rs 55.8 crore from Rs 58.2 crore in the previous quarter (Q4 FY25). This dip came despite a strong rise in revenue from operations, which grew 9.56 per cent sequentially to Rs 526.3 crore from Rs 480.4 crore, according to its stock exchange filing. Other income saw a sharp decline of 30.43 per cent, dropping to Rs 11.2 crore from Rs 16.1 crore in Q4 FY25. However, total income rose 8.23 per cent to Rs 537.5 crore from Rs 496.6 crore, driven by solid operational performance. Total expenses increased by 12.12 per cent to Rs 462.4 crore, compared to Rs 412.4 crore in the previous quarter, the company stated in its regulatory filing. Bhavana Agrawal, Chief Financial Officer and Director of the Company, said the strong quarterly performance reflects the power of science-led innovation combined with disciplined execution. 'Each regulatory milestone brings us closer to transforming outcomes for patients living with chronic diseases. We remain focused on expanding our portfolio, strengthening partnerships, and ensuring that breakthrough medicines reach the people who need them most,' she added. Praveen Rao Akkinepally, Country President and Managing Director, said that delivering consistent growth across therapy areas reaffirms the strength of the company's 'Growth Through Innovation' strategy. 'These results are a testament to what is possible when science and purpose come together,' he noted. AstraZeneca, a global science-led biopharmaceutical company, focuses on the discovery, development, and commercialisation of prescription medicines, primarily in oncology, cardiovascular, renal and metabolism, respiratory, and rare diseases. The company operates in over 100 countries, with its medicines used by millions of patients worldwide. Completing 45 years in India, AstraZeneca Pharma India Limited is headquartered in Bengaluru and employs over 600 people across the country.


News18
2 hours ago
- News18
Cash On 'Delivery': This Country Is Paying Couples To Have Children; The Amount Will Blow Your Mind
The proposal, expected to secure cabinet approval soon, will extend the subsidy across multiple stages of IVF treatment, from the first attempt through the sixth In a bold move to counter its declining birth rate, Taiwan has announced a significant expansion of its financial support for couples seeking to have children through in-vitro fertilisation (IVF). The government will now offer up to Rs 6 lakh in assistance, more than double the current Rs 3 lakh, in an effort to make the costly procedure more accessible. The proposal, expected to secure cabinet approval soon, will extend the subsidy across multiple stages of IVF treatment, from the first attempt through the sixth. Until now, only the initial stage received such support. Officials said that the change addresses a key deterrent; IVF often requires several rounds to succeed, and many couples abandon the process due to escalating costs. Governments across the region are experimenting with incentives to boost birth rates. China, grappling with the long-term effects of its one-child policy, has introduced a national child-care subsidy starting January 2025 – 3,600 yuan (around Rs 43,000) annually for every child under three, with additional state-level benefits. Russia, facing a similar demographic crunch, offers Rs 6.65 lakh for a first child and Rs 8.70 lakh for a second. Some regions have gone further, extending payments even to schoolgirls who become pregnant. For Taiwan, officials hope that easing the financial burden of IVF will help reverse a trend that, if left unchecked, could reshape the nation's economy and workforce in the decades ahead. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.


NDTV
3 hours ago
- NDTV
Top 10 Nursing Colleges In India: Courses, Admissions, Duration
Pursuing a Bachelor of Science (BSc) in Nursing from a reputed institution is a crucial step for those aiming to build a successful career in healthcare. India's leading nursing colleges are known for combining strong academic training with extensive clinical exposure, research opportunities, and skill development. As per the latest rankings, the top institutes offering BSc Nursing include AIIMS Delhi, PGIMER Chandigarh, Christian Medical College (Vellore), National Institute of Mental Health and Neuro Sciences (Bengaluru), Jawaharlal Institute of Postgraduate Medical Education and Research (Puducherry), Sanjay Gandhi Postgraduate Institute of Medical Sciences, Banaras Hindu University, Amrita Vishwa Vidyapeetham, Kasturba Medical College (Manipal), and Madras Medical College. Admissions and Eligibility Candidates must have completed Class 12 with at least 55% in Physics, Chemistry, and Biology from a recognised board. Admissions are based on either Class 12 merit or entrance exams such as KCET, AP EAMCET, JENPAS UG, TS EAMCET, NEET, or CUET. While NEET is not mandatory, some institutions use it for shortlisting. Programme Highlights AIIMS Delhi: Four-year BSc Nursing with 77 seats; NEET-based admission; tuition fee Rs 600. Offers specialisations including Pediatric, Psychiatric, and Critical Care Nursing. PGIMER Chandigarh: Offers BSc and Post-Basic BSc Nursing; entrance exam in June; tuition fee Rs 1,000. CMC Vellore: Established in 1946; tuition fee Rs 810 per year; multiple nursing specialisations; scholarships available. NIMHANS Bengaluru: Focus on psychiatric and neurological nursing; total cost Rs 1.4 lakh. JIPMER Puducherry: NEET-based admission; 94 seats; mandatory 24-week paid internship; annual fee Rs 5,760. These institutions not only prepare students for roles in top hospitals but also equip them for higher studies and community healthcare roles, making them some of the most sought-after destinations for nursing education in India.